Physician profile

Gregory R Eissmann

General Practice (Dentist) · Reno, NV

NPI 1134142045

$5,055.52

in general payments reported to CMS, 2019-2025

7 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Gift$3,991.63
Education$41.99
Food and Beverage$21.30

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Ultradent Products INC $4,335.15 2022-2024 Opalescence
A-Dec, INC. $465.50 2020
Straumann USA LLC $136.32 2019
Philips North America LLC $41.99 2023
Dentsply Sirona INC $32.49 2019-2024 Algin-X Ultra Alginate Alternative
Hu-Friedy Mfg. Co., LLC $25.00 2021
Henry Schein, INC. $19.07 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Gregory R Eissmann

$5,055.52

in general payments reported 2019-2025

Years
2019-2024
Top company
Ultradent Products INC

https://glasscript.com/doctor/395227/gregory-r-eissmann

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.